Exegiline


MT-031 is a multifunctional drug designed for the treatment of dementia and Alzheimer Disease. Its structure combines Rivastigmine (Exelon) and Rasagiline (Azilect) moieties. It works as a dual Acetylcholinesterase (AChE) and Butyrylcholinesterase (BuChE) inhibitor as well a selective irreversible inhibition of MAO-A

Our findings demonstrated that MT-031 has the following attributes:

  • A brain permeable novel multifunctional MAO-AChE/BuChe inhibitor
  • Possesses neuroprotective activity
  • Anti-inflammatory properties
  • Cognitive enhancing activity’s
  • Memory enhancing
  • Intellectual Property

    The molecule, its derivatives and applications are protected by the US and European recently granted patent.

    Read more

    ResQ Medical


    Controlling The Bleeding In Time

    ResQ Medical is developing ALMA, a unique and innovative solution for treating Postpartum Hemorrhage (PPH) which is a life-threatening condition.

    ALMA is attentive to the natural physiological mechanism of the uterus to deal with PPH.

    Our approach with ALMA is to support the natural contraction of the uterus which in turn leads to the cessation of the bleeding as occurring naturally in any normal birth, and which doesn’t occur in the case of PPH. This innovative approach contrasts with the medical devices used today, which are based on inserting and inflating a balloon inside the uterine cavity- causing the uterus to expend against the natural mechanism of the body.

    Read more

    www.Resq-Med.com

    Surgical KIS


    Surgical Knotless Innovation Solutions

    Surgical KIS is developing an innovative system, the SLEEK suture. This system will allow surgeons to attach the artificial valve to the heart tissues more efficiently, quickly, and precisely than the conventional manual method. The system will be user-friendly, have a lower cost than the competitor’s, be efficient, and free of metallic components.

    Open-heart surgeries for valve replacement pose a significant challenge in modern medicine. The main problem lies in the complexity of the procedure, its long duration, and the associated risks.

    Read more

    Endopump


    The new generation of therapy for Parkinson .

    EndoPump is developing a new method of treatment to help in the management of Parkinson disease using an implanted continuous delivering system to deliver Levodopa by a unique formulation, achieving stable blood concentrations for 24/7 avoiding unnecessary side effects

    The unique technology is implanted, and filled once in a week.

    Dose controlled by the EndoPump Application by physician and patient.

    achieving stable blood concentrations for 24/7 in any conditions.

    internal, discreet, reduced risk of infection and comfortable for the Parkinson patient.

    www.endo-pump.com

    Mitralheal


    MitralHeal Ltd. A novel catheter based technology replacement valve to replace a defective mitral valve for treating mitral regurgitation. Mitralheal’s System will allow physicians to offer therapy to patients who suffer from mitral regurgitation, and who currently have no good and safe solution/intervention for their condition. Mitralheal’s solution has the ability to provide patients with a new method to treat mitral valve diseases other than surgery-based or repair-only options, by a minimally invasive procedure. Thus, providing clinical benefit over mitral valve replacement surgery, with lower risks associated with minimally invasive approach.

    Founded in 2012 by Youdim Pharmaceuticals with IP from Sheba Medical Center, the largest hospital in Israel and recognized among the top 10 in the world by Newsweek in 2019, 2020, 2021, and a teaching hospital of Tel Aviv University.

    Read more